Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents.
Hideko OhamaAtsushi HiraokaToshifumi TadaKazuya KariyamaEi ItobayashiKunihiko TsujiToru IshikawaHidenori ToyodaTakeshi HatanakaSatoru KakizakiAtsushi NaganumaFujimasa TadaHironori TanakaShinichiro NakamuraKazuhiro NousoKazunari TanakaTakashi Kumadanull nullPublished in: Journal of gastroenterology and hepatology (2024)
The development of DAA therapy has dramatically improved the prognosis of HCV-HCC patients.